Skip to main content
Valentina Nardi, MD, Pathology, Boston, MA

Valentina Nardi MD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology


Assistant pathologist, Massachusetts General Hospital

Join to View Full Profile
  • 101 Nicolls RdBoston, MA 11794

  • Phone+1 617-726-2967

  • Fax+1 617-726-7474

Dr. Nardi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2012 - 2013
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Hematopathology, 2010 - 2012
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2012
  • Univ Genoa- Fac Med
    Univ Genoa- Fac MedClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2026
  • Pathology - Anatomic
    American Board of Pathology Pathology - Anatomic
  • Pathology - Molecular Genetic
    American Board of Pathology Pathology - Molecular Genetic
  • Hematopathology
    American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Abstracts/Posters

  • Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera
    Valentina Nardi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Newly Characterized Mutation May Define a Novel Leukemia Subtype in Kids
    Newly Characterized Mutation May Define a Novel Leukemia Subtype in KidsFebruary 24th, 2022
  • Newly Characterized Mutation May Define Novel Pediatric AML Subtype
    Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
  • Case 37-2019: A 20-Month-Old Boy with Severe Anemia
    Case 37-2019: A 20-Month-Old Boy with Severe AnemiaNovember 28th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: